Background
Internationally, intimate partner violence (IPV) cohorts have demonstrated associations with depression and anxiety. However, this association has not yet been described in a UK population, nor has the association with serious mental illness (SMI).
Aims
To explore the relationship between IPV exposure and mental illness in a UK population.
Method
We designed a retrospective cohort study whereby we matched 18 547 women exposed to IPV to 74 188 unexposed women. Outcomes of interest (anxiety, depression and SMI) were identified through clinical codes.
Results
At baseline, 9174 (49.5%) women in the exposed group had some form of mental illness compared with 17 768 (24.0%) in the unexposed group, described as an adjusted odds ratio of 2.62 (95% CI 2.52–2.72). Excluding those with mental illness at baseline, 1254 exposed women (incidence rate 46.62 per 1000 person-years) went on to present with any type of mental illness compared with 3119 unexposed women (incidence rate 14.93 per 1000 person-years), with an aIRR of 2.77 (95% CI 2.58–2.97). Anxiety (aIRR 1.99, 95% CI 1.80–2.20), depression (aIRR 3.05, 95% CI 2.81–3.31) and SMI (aIRR 3.08, 95% CI 2.19–4.32) were all associated with exposure to IPV.
Conclusions
IPV remains a significant public health issue in the UK. We have demonstrated the significant recorded mental health burden associated with IPV in primary care, at both baseline and following exposure. Clinicians must be aware of this association to reduce mental illness diagnostic delay and improve management of psychological outcomes in this group of patients.
Declaration of interest
None.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document. When citing, please reference the published version. Take down policy While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been uploaded in error or has been deemed to be commercially or otherwise sensitive.
Background
Domestic abuse (
DA
) against women is a global public health problem. Although the possible health burden could be substantial, the associations between
DA
and subsequent cardiometabolic disease (cardiovascular disease, hypertension, and type 2 diabetes mellitus) and all‐cause mortality are poorly understood.
Methods and Results
This retrospective cohort study consisted of
UK
‐based primary care patients between January 1, 1995, to December 1, 2017. Overall, 18 547 women exposed to
DA
were matched to 72 231 unexposed women by age and lifestyle factors. The main outcomes, presented as adjusted incidence rate ratios (
IRRs
), were the risk of developing cardiovascular disease, hypertension, type 2 diabetes mellitus, and all‐cause mortality. In total, 181 exposed women experienced a cardiovascular disease event compared with 644 of the unexposed control group, relating to an increased adjusted
IRR
of 1.31 (95%
CI
, 1.11–1.55;
P
=0.001). There was also an increased risk of subsequent type 2 diabetes mellitus (adjusted IRR: 1.51; 95%
CI
, 1.30–1.76;
P
<0.001) and all‐cause mortality (adjusted IRR: 1.44; 95%
CI
, 1.24–1.67;
P
<0.001) following exposure to
DA
. This observation was not seen with hypertension (adjusted
IRR
: 0.99; 95%
CI
, 0.88–1.12;
P
=0.873).
Conclusions
There is an increased risk of subsequent cardiovascular disease, type 2 diabetes mellitus, and all‐cause mortality in female survivors of
DA
. However, there is no association with the development of hypertension in this group, in keeping with previous literature. Considering the high prevalence of
DA
, clinicians should be made aware of the disproportionally increased risk and thus are encouraged to manage modifiable risk factors actively in this group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.